PACLITAXEL , GEMCITABINE , CARBOPLATIN , BNT327, Abraxane 5 mg/ml powder for dispersion for infusion., ERIBULIN , BNT327 Placebo
BNT327-05
Phase 3 small_molecule active
Quick answer
PACLITAXEL , GEMCITABINE , CARBOPLATIN , BNT327, Abraxane 5 mg/ml powder for dispersion for infusion., ERIBULIN , BNT327 Placebo for First line triple-negative breast cancer (TNBC) is a Phase 3 program (small_molecule) at BioNTech Manufacturing GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BioNTech Manufacturing GmbH
- Indication
- First line triple-negative breast cancer (TNBC)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active